Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2007
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849480A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
10/31/2007EP1849470A1 Anticancer drug containing alpha, alpha, alphatrifluorothymidine and thymidine phosphorylase inhibitor
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1849467A1 The synergistically pharmaceutical composition of baicalein and baicalin for inhibiting tumor
10/31/2007EP1848778A2 De novo synthesis of bacteriochlorins
10/31/2007EP1848742A1 Anti-prl-3 antibodies and methods of use thereof
10/31/2007EP1848727A1 Ibandronate polymorph b
10/31/2007EP1848719A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
10/31/2007EP1848718A1 Inhibitors of e1 activating enzymes
10/31/2007EP1848717A2 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy
10/31/2007EP1848715A1 Compounds having tie2 (tek) inhibitory activity
10/31/2007EP1848714A2 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
10/31/2007EP1848704A1 Novel tubulin polymerisation inhibitors
10/31/2007EP1848698A2 Quinoxaline derivatives as antitumor agents
10/31/2007EP1848506A2 Pyrimidine-fused diazepine derivatives and indole-fused pteridines
10/31/2007EP1848456A2 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
10/31/2007EP1848454A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody
10/31/2007EP1848442A1 2-methylene-19-nor-(20s-24epi)-1alpha,25-dihydroxyvitamine-d2
10/31/2007EP1848433A2 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
10/31/2007EP1848429A1 Pharmaceutical agents containing fluoroalkylated metal complexes and epothilone
10/31/2007EP1848423A2 C10 cyclopropyl ester substituted taxane compositions
10/31/2007EP1848418A2 Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection
10/31/2007EP1848414A2 Method for treating gefitinib resistant cancer
10/31/2007EP1848290A2 Compositions and methods for nutrition supplementation
10/31/2007EP1644380B1 Biologically active neopeltolide compounds
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1503760A4 Camptothecin derivatives and polymeric conjugates thereof
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1470143B1 Compounds that inhibit factor xa activity
10/31/2007EP1448551B1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
10/31/2007EP1425974B1 A method for processing tea flower
10/31/2007EP1372691B1 Mucin peptide with immunoenhancing properties
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1259626B1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP1140198B1 Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP0871645B1 Modulators of the function of fas/apo1 receptors
10/31/2007DE102006019907A1 Use of substituted glycerin derivative in the preparation of a pharmaceutical composition for the prevention or treatment of e.g. cancer disease, pathological sequence of alcohol abuse, viral hepatitis and toxic nerve disorder
10/31/2007DE102006019906A1 Verwendung von Verbindungen der Formel ARX oder deren pharmazeutisch akzeptable Salze zur Herstellung einer pharmazeutischen Zubereitung Use of compounds of the formula ARX, or their pharmaceutically acceptable salts for the manufacture of a pharmaceutical preparation
10/31/2007DE102006019589A1 Inhibitoren des TASK-1 und Task-3 Ionenkanals Inhibitors of the TASK-1 and Task 3 ion channel
10/31/2007DE102005055355A1 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate 3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazine derivatives
10/31/2007DE102005055354A1 Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine Substituted 5-phenyl-3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazine
10/31/2007CN101065485A LNA oligonucleotides and the treatment of cancer
10/31/2007CN101065482A Novel shuttle vector
10/31/2007CN101065365A Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
10/31/2007CN101065362A 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
10/31/2007CN101065361A Bengamides with a substituted caprolactame cycle, method forthe preparation thereof, compositions containing them and use thereof
10/31/2007CN101065360A Thermodynamically stable form of BAY 43-9006 tosylate
10/31/2007CN101065358A 3-arylamino pyridine derivatives
10/31/2007CN101065150A 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
10/31/2007CN101065147A Naturally occurring IgM antibodies that bind lymphocytes
10/31/2007CN101065144A Methods and compositions for treatment of hematologic cancers
10/31/2007CN101065129A A combination of n-(3-metoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic agent for the treatment of cancer
10/31/2007CN101065127A Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof
10/31/2007CN101065126A Use of epothilones in the treatment of bone metastases and bone tumors or cancers
10/31/2007CN101065120A 4-hydroxy tamoxifen gel formulations
10/31/2007CN101063142A Human papilloma virus 16 type DNA vaccine and gene adjuvant and its application
10/31/2007CN101063130A Recombined protein having phenotypic knock-out effect on chemotropism factor receptor CXCR4
10/31/2007CN101063112A Nucleoside diphosphokinase A oxidation-reduction isomer
10/31/2007CN101062955A Fusion protein having inhibitory action on tumour cell and its coding gene and application
10/31/2007CN101062954A Fusion protein having blood vessel formation against function and its coding gene and application
10/31/2007CN101062952A Fusion protein comprised of human serum and interferon and its coding gene and application
10/31/2007CN101062945A Meretrix meretrix protein having antineoplastic action, gene order and preparation method thereof
10/31/2007CN101062925A Paclitaxel derivatives, preparation method and medicinal composition and usage thereof
10/31/2007CN101062895A Iso chicoric acid and extraction separation method thereof and usage in medicament
10/31/2007CN101062419A Polymer conjugates of interferon beta-1a and uses
10/31/2007CN101062416A Glucan ferroferric oxide magnetic nano-material and the preparing method thereof and the application
10/31/2007CN101062406A Reeombinnt human granulocyte colony stimulating factor microemulsion
10/31/2007CN101062404A Pidotimod injection and the producing method thereof
10/31/2007CN101062382A External application analgesic preparation for patients with gastric cancer and the preparing method thereof
10/31/2007CN101062374A Method for preparing Chinese traditional combination capsule for treating cancer and the product thereof
10/31/2007CN101062358A Chinese medicine for treating leukemia
10/31/2007CN101062292A Medicine for treating cancer and preventing lung cancer and preparing method thereof
10/31/2007CN101062279A Oral liquid for treating cancer and preparing method thereof
10/31/2007CN101062240A Traditional Chinese medicine preparation for treating leukocythemia
10/31/2007CN101062215A Chinese traditional medicine powder took orally for treating cancer pain
10/31/2007CN101062146A Chinese traditional medicine for treating gastric cancer and bone cancer
10/31/2007CN101062117A Capsule for eliminating phlegm and relaxing heart
10/31/2007CN101062098A Compound priceless healthy energy capsule
10/31/2007CN101062090A Method for preparing the agent for relieving the pain of cancer patients
10/31/2007CN101062079A Anti-cancer Chinese traditional medicine of southernwood fibril and the preparing method thereof
10/31/2007CN101062062A Method for preparing anti-cancer effective component of marine animals
10/31/2007CN101062061A Method for preparing analgesic preparation in external use
10/31/2007CN101062053A Reduced toxicity cisplatin formulations and methods for using the same
10/31/2007CN101062049A Medical combination of teniposide, the preparing method and the function thereof
10/31/2007CN101062045A Novel function of triterpene saponin compounds
10/31/2007CN101062043A Application of 3, 4, 5, 4'-tetramethyl diphenylethane-3'-O-disodium phosphate in the anti-cancer medicine and the transferring medicine thereof
10/31/2007CN101062040A Stable type cucurbitacin liquid formula and the agent thereof
10/31/2007CN101062029A Application of wogonin in the preparing of medicine for treating gastric cancer
10/31/2007CN101062028A Combination including taxanes, the preparing method and the use thereof
10/31/2007CN101062026A Function of pseudolarix acetic acid as medicine for inducing tumor cells to die
10/31/2007CN101062023A Selective androgen receptor modulators and methods of use thereof
10/31/2007CN101062016A Immune micro-liposomal used in the cancer developing, diagnosing and treating and the application thereof
10/31/2007CN101061887A Cancer-proof cigarette made by paclitaxel and the method of producing the same
10/31/2007CN101061885A Method of producing body-strengthening type food made of agaric
10/31/2007CN101061860A Leucine-rich nutritional compositions
1 ... 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 ... 2211